Short Interest in Daxor Co. (NASDAQ:DXR) Increases By 13.8%

Daxor Co. (NASDAQ:DXRGet Free Report) was the target of a large increase in short interest in the month of May. As of May 31st, there was short interest totalling 6,600 shares, an increase of 13.8% from the May 15th total of 5,800 shares. Approximately 0.3% of the shares of the company are short sold. Based on an average daily trading volume, of 2,300 shares, the short-interest ratio is presently 2.9 days.

Daxor Stock Performance

NASDAQ DXR traded down $0.17 during midday trading on Tuesday, hitting $8.83. The company had a trading volume of 377 shares, compared to its average volume of 1,089. The firm has a fifty day simple moving average of $9.43 and a two-hundred day simple moving average of $8.90. Daxor has a fifty-two week low of $7.11 and a fifty-two week high of $10.15.

Daxor Company Profile

(Get Free Report)

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions.

See Also

Receive News & Ratings for Daxor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daxor and related companies with MarketBeat.com's FREE daily email newsletter.